U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT06930807) titled 'Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer' on March 25.
Brief Summary: The goal of this study is to develop new techniques for minimal residual disease(MRD) monitoring and to confirm the efficacy and safety of MRD-guided postoperative management for early stage non-small cell lung cancer. The main questions this study aims to answer are:
* How to develop multi-omics-based high-sensitivity detection methods to accurately capture MRD and monitor postoperative recurrence in lung cancer?
* Is adaptive treatment guided by ctDNA-MRD for lung cancer patients superior to traditional clinical managemen...